CLINICAL EXPERIENCE WITH THE ANTIVIRAL DRUG MARBORAN® (1-METHYLISATIN 3-THIOSEMICARBAZONE) *
1
Wellcome Loboratories of Tropical Medicine, London, England
|
Publication type: Journal Article
Publication date: 2006-12-16
scimago Q1
wos Q1
SJR: 1.458
CiteScore: 10.3
Impact factor: 4.8
ISSN: 00778923, 17496632
PubMed ID:
5323377
General Biochemistry, Genetics and Molecular Biology
General Neuroscience
History and Philosophy of Science
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
Antiviral Research
6 publications, 6.82%
|
|
|
Pharmacology and Therapeutics
4 publications, 4.55%
|
|
|
Dermatologic Clinics
2 publications, 2.27%
|
|
|
New England Journal of Medicine
2 publications, 2.27%
|
|
|
American Journal of Medicine
2 publications, 2.27%
|
|
|
ACS Omega
2 publications, 2.27%
|
|
|
Journal of Heterocyclic Chemistry
2 publications, 2.27%
|
|
|
Annals of the New York Academy of Sciences
2 publications, 2.27%
|
|
|
Journal für praktische Chemie
2 publications, 2.27%
|
|
|
Rapid Communications in Mass Spectrometry
2 publications, 2.27%
|
|
|
British Journal of Dermatology
2 publications, 2.27%
|
|
|
Mayo Clinic Proceedings
2 publications, 2.27%
|
|
|
Current Topics in Medicinal Chemistry
1 publication, 1.14%
|
|
|
Mini-Reviews in Medicinal Chemistry
1 publication, 1.14%
|
|
|
Journal of Molecular Structure THEOCHEM
1 publication, 1.14%
|
|
|
Antiviral Chemistry and Chemotherapy
1 publication, 1.14%
|
|
|
Structural Chemistry
1 publication, 1.14%
|
|
|
Virology Journal
1 publication, 1.14%
|
|
|
Indian Journal of Pediatrics
1 publication, 1.14%
|
|
|
Archives of Virology
1 publication, 1.14%
|
|
|
Pharmaceutical Chemistry Journal
1 publication, 1.14%
|
|
|
Nature New Biology
1 publication, 1.14%
|
|
|
Biochemical and Biophysical Research Communications
1 publication, 1.14%
|
|
|
Current Problems in Pediatrics
1 publication, 1.14%
|
|
|
Journal of Investigative Dermatology
1 publication, 1.14%
|
|
|
Bioorganic and Medicinal Chemistry Letters
1 publication, 1.14%
|
|
|
Medicina Universitaria
1 publication, 1.14%
|
|
|
Bioorganic and Medicinal Chemistry
1 publication, 1.14%
|
|
|
Vaccine
1 publication, 1.14%
|
|
|
1
2
3
4
5
6
|
Publishers
|
5
10
15
20
25
30
35
|
|
|
Elsevier
34 publications, 38.64%
|
|
|
Wiley
16 publications, 18.18%
|
|
|
Springer Nature
10 publications, 11.36%
|
|
|
Taylor & Francis
4 publications, 4.55%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 2.27%
|
|
|
Massachusetts Medical Society
2 publications, 2.27%
|
|
|
American Chemical Society (ACS)
2 publications, 2.27%
|
|
|
Hindawi Limited
2 publications, 2.27%
|
|
|
SAGE
1 publication, 1.14%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 1.14%
|
|
|
Institute of Molecular Biology and Genetics (NAS Ukraine)
1 publication, 1.14%
|
|
|
Walter de Gruyter
1 publication, 1.14%
|
|
|
American Society for Microbiology
1 publication, 1.14%
|
|
|
Pleiades Publishing
1 publication, 1.14%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 1.14%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 1.14%
|
|
|
Georg Thieme Verlag KG
1 publication, 1.14%
|
|
|
5
10
15
20
25
30
35
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
88
Total citations:
88
Citations from 2025:
2
(2.27%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Bauer D. J. CLINICAL EXPERIENCE WITH THE ANTIVIRAL DRUG MARBORAN® (1-METHYLISATIN 3-THIOSEMICARBAZONE) * // Annals of the New York Academy of Sciences. 2006. Vol. 130. No. 1. pp. 110-117.
GOST all authors (up to 50)
Copy
Bauer D. J. CLINICAL EXPERIENCE WITH THE ANTIVIRAL DRUG MARBORAN® (1-METHYLISATIN 3-THIOSEMICARBAZONE) * // Annals of the New York Academy of Sciences. 2006. Vol. 130. No. 1. pp. 110-117.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1111/j.1749-6632.1965.tb12545.x
UR - https://doi.org/10.1111/j.1749-6632.1965.tb12545.x
TI - CLINICAL EXPERIENCE WITH THE ANTIVIRAL DRUG MARBORAN® (1-METHYLISATIN 3-THIOSEMICARBAZONE) *
T2 - Annals of the New York Academy of Sciences
AU - Bauer, D. J.
PY - 2006
DA - 2006/12/16
PB - Wiley
SP - 110-117
IS - 1
VL - 130
PMID - 5323377
SN - 0077-8923
SN - 1749-6632
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2006_Bauer,
author = {D. J. Bauer},
title = {CLINICAL EXPERIENCE WITH THE ANTIVIRAL DRUG MARBORAN® (1-METHYLISATIN 3-THIOSEMICARBAZONE) *},
journal = {Annals of the New York Academy of Sciences},
year = {2006},
volume = {130},
publisher = {Wiley},
month = {dec},
url = {https://doi.org/10.1111/j.1749-6632.1965.tb12545.x},
number = {1},
pages = {110--117},
doi = {10.1111/j.1749-6632.1965.tb12545.x}
}
Cite this
MLA
Copy
Bauer, D. J.. “CLINICAL EXPERIENCE WITH THE ANTIVIRAL DRUG MARBORAN® (1-METHYLISATIN 3-THIOSEMICARBAZONE) *.” Annals of the New York Academy of Sciences, vol. 130, no. 1, Dec. 2006, pp. 110-117. https://doi.org/10.1111/j.1749-6632.1965.tb12545.x.